Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer by combining a unique, highly immunogenic source of neoantigens with a peptide array platform. On our course to eradicate cancer we will develop new diagnostic and therapeutic products, and then preventative vaccines that will stop cancer from starting.
- Clinical trials are in progress to demonstrate the feasibility of providing prophylactic vaccines that prevent cancer.
- Partnerships are formed to collaboratively established the viability of early cancer diagnosis.
- FAST vaccine trials are being initiated that could dramatically reduce the time and expense of cancer treatments.
